Quality-of-life and quality-adjusted survival (Q-TWiST) in patients receiving lapatinib in combination with paclitaxel as first-line treatment for metastatic breast cancer

By Sherrill Beth   Di Leo Angelo   Amonkar Mayur M.   Wu Yun   Zvirbule Zanete   Aziz Zeba   Bines Jose   Gomez Henry L.  

Current Medical Research and Opinion, Vol. 26, Iss. 4, 2010-04 ,pp. : 767-775

Informa Healthcare

Access to resources Recommend Favorite

Quality-adjusted survival analysis of first-line treatment of hormone-receptor-positive HER2++ metastatic breast cancer with letrozole alone or in combination with lapatinib

By Sherrill Beth   Sherif Bintu   Amonkar Mayur M.   Maltzman Julie   O’Rourke Lisa   Johnston Stephen  

Current Medical Research and Opinion, Vol. 27, Iss. 12, 2011-12 ,pp. : 2245-2252

Informa Healthcare

Access to resources Recommend Favorite

Assessing the need for quality-adjusted cost–effectiveness studies of nanotechnological cancer therapies

By Bosetti Rita   Marneffe Wim   Vereeck Lode  

Nanomedicine, Vol. 8, Iss. 3, 2013-03 ,pp. : 487-497

Future Medicine

Access to resources Recommend Favorite

Quality‐adjusted time without symptoms or toxicity (Q‐TWiST): patient‐reported outcome or mathematical model? A systematic review in cancer

By  

PSYCHO-ONCOLOGY (ELECTRONIC), Vol. 24, Iss. 3, 2015-03 ,pp. : 253-261

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of selected risk factors on quality-adjusted life expectancy in Denmark

By Brønnum-Hansen Henrik  

Scandinavian Journal of Public Health, Vol. 35, Iss. 5, 2007-01 ,pp. : 510-515

Informa Healthcare

Access to resources Recommend Favorite